2 citations
,
July 2013 in “InTech eBooks” This article reviews the differences between scarring and non-scarring alopecias and describes diagnostic methods but reports no new clinical findings.
20 citations
,
July 2000 in “PubMed” This article describes an organized diagnostic approach for identifying nonscarring and scarring alopecias to aid family physicians in making accurate in-office diagnoses, but it reports no new clinical findings.
6 citations
,
December 1997 in “Journal of The American Academy of Dermatology” CTE can distort results in hair growth trials, so exclude it carefully.
2 citations
,
December 1997 in “Journal of The American Academy of Dermatology” The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.
January 2014 in “Pathology” RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.